66 related articles for article (PubMed ID: 19495867)
1. Development of the 'PREDICT' score through a systematic review and meta-analysis of the predictive parameters for locoregional recurrence after total mesorectal excision.
Khan SM; Emile SH; Barsom SH; Ahsan SO
Updates Surg; 2021 Feb; 73(1):35-46. PubMed ID: 32734579
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Implication of Negative Lymph Node Count in ypN+ Rectal Cancer after Neoadjuvant Chemoradiotherapy and Construction of a Prediction Nomogram.
Sun Y; Zhang Y; Huang Z; Chi P
J Gastrointest Surg; 2019 May; 23(5):1006-1014. PubMed ID: 30187336
[TBL] [Abstract][Full Text] [Related]
3. Clinical Pattern of Recurrent Disease during the Follow-Up of Rectal Carcinoma.
Wieldraaijer T; Bruin P; Duineveld LAM; Tanis PJ; Smits AB; van Weert HCPM; Wind J
Dig Surg; 2018; 35(1):35-41. PubMed ID: 28288461
[TBL] [Abstract][Full Text] [Related]
4. Tumor compactness improves the preoperative volumetry-based prediction of the pathological complete response of rectal cancer after preoperative concurrent chemoradiotherapy.
Hsu CY; Wang CW; Kuo CC; Chen YH; Lan KH; Cheng AL; Kuo SH
Oncotarget; 2017 Jan; 8(5):7921-7934. PubMed ID: 27974702
[TBL] [Abstract][Full Text] [Related]
5. The number of retrieved lymph nodes needed for accurate staging differs based on the presence of preoperative chemoradiation for rectal cancer.
Han J; Noh GT; Yeo SA; Cheong C; Cho MS; Hur H; Min BS; Lee KY; Kim NK
Medicine (Baltimore); 2016 Sep; 95(38):e4891. PubMed ID: 27661032
[TBL] [Abstract][Full Text] [Related]
6. A scoring system basing pathological parameters to predict regional lymph node metastasis after preoperative chemoradiotherapy for locally advanced rectal cancer: implication for local excision.
Wang XJ; Chi P; Lin HM; Lu XR; Huang Y; Xu ZB; Huang SH; Sun YW; Ye DX; Yu Q
Oncotarget; 2016 Nov; 7(48):78487-78498. PubMed ID: 27489356
[TBL] [Abstract][Full Text] [Related]
7. Oncologic Impact of Fewer Than 12 Lymph Nodes in Patients Who Underwent Neoadjuvant Chemoradiation Followed by Total Mesorectal Excision for Locally Advanced Rectal Cancer.
Kim WR; Han YD; Cho MS; Hur H; Min BS; Lee KY; Kim NK
Medicine (Baltimore); 2015 Jul; 94(28):e1133. PubMed ID: 26181550
[TBL] [Abstract][Full Text] [Related]
8. Multidisciplinary treatment of rectal cancer in 2014: where are we going?
Vignali A; De Nardi P
World J Gastroenterol; 2014 Aug; 20(32):11249-61. PubMed ID: 25170209
[TBL] [Abstract][Full Text] [Related]
9. Circumferential resection margins of rectal tumours post-radiotherapy: how can MRI aid surgical planning?
McGlone ER; Shah V; Lowdell C; Blunt D; Cohen P; Dawson PM
Tech Coloproctol; 2014 Oct; 18(10):937-43. PubMed ID: 25037073
[TBL] [Abstract][Full Text] [Related]
10. Coexistence of perineural invasion and lymph node metastases is a poor prognostic factor in patients with locally advanced rectal cancer after preoperative chemoradiotherapy followed by radical resection and adjuvant chemotherapy.
Huang CM; Huang CW; Huang MY; Lin CH; Chen CF; Yeh YS; Ma CJ; Huang CJ; Wang JY
Med Princ Pract; 2014; 23(5):465-70. PubMed ID: 25012611
[TBL] [Abstract][Full Text] [Related]
11. Number of lymph nodes after neoadjuvant therapy for rectal cancer: How many are needed?
Scabini S; Ferrando V
World J Gastrointest Surg; 2012 Feb; 4(2):32-5. PubMed ID: 22408716
[TBL] [Abstract][Full Text] [Related]
12. Oncologic outcomes of primary and post-irradiated early stage rectal cancer: a retrospective cohort study.
Du CZ; Chen YC; Cai Y; Xue WC; Gu J
World J Gastroenterol; 2011 Jul; 17(27):3229-34. PubMed ID: 21912472
[TBL] [Abstract][Full Text] [Related]
13. Recurrence rates and prognostic factors in ypN0 rectal cancer after neoadjuvant chemoradiation and total mesorectal excision.
Govindarajan A; Reidy D; Weiser MR; Paty PB; Temple LK; Guillem JG; Saltz LB; Wong WD; Nash GM
Ann Surg Oncol; 2011 Dec; 18(13):3666-72. PubMed ID: 21590450
[TBL] [Abstract][Full Text] [Related]
14. Long-term prognostic value of mesorectal grading after neoadjuvant chemoradiotherapy for rectal cancer.
Madbouly KM; Hussein AM; Abdelzaher E
Am J Surg; 2014 Sep; 208(3):332-41. PubMed ID: 24581995
[TBL] [Abstract][Full Text] [Related]
15. Metastatic lymph node ratio in stage III rectal carcinoma is a valuable prognostic factor even with less than 12 lymph nodes retrieved: a prospective study.
Madbouly KM; Abbas KS; Hussein AM
Am J Surg; 2014 Jun; 207(6):824-31. PubMed ID: 24112666
[TBL] [Abstract][Full Text] [Related]
16. [Neoadjuvant treatment for rectal cancer].
Bachet JB; Benoist S; Mas L; Huguet F
Bull Cancer; 2021 Sep; 108(9):855-867. PubMed ID: 34140155
[TBL] [Abstract][Full Text] [Related]
17. [Rectal cancer. How much radiotherapy do surgery patients need?].
Ulrich A; Weitz J; Büchler MW
Chirurg; 2009 Apr; 80(4):266-73. PubMed ID: 19271158
[TBL] [Abstract][Full Text] [Related]
18. Factors associated with local recurrence after neoadjuvant chemoradiation with total mesorectal excision for rectal cancer.
Kim NK; Kim YW; Min BS; Lee KY; Sohn SK; Cho CH
World J Surg; 2009 Aug; 33(8):1741-9. PubMed ID: 19495867
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
